Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape.
about
Comparative expression profile of miRNA and mRNA in primary peripheral blood mononuclear cells infected with human immunodeficiency virus (HIV-1)Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital MucosaEnhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individualsInsufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cellsIncorporation of CD40 ligand into the envelope of pseudotyped single-cycle Simian immunodeficiency viruses enhances immunogenicity.The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90HIV-1 infection of DC: evidence for the acquisition of virus particles from infected T cells by antigen uptake mechanism.Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapyInteractions with DCAF1 and DDB1 in the CRL4 E3 ubiquitin ligase are required for Vpr-mediated G2 arrest.Differential effects of Vpr on single-cycle and spreading HIV-1 infections in CD4+ T-cells and dendritic cells.Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that are associated with levels of plasma viremia and T cell activation in an exploratDevelopment of a robust cell-based high-throughput screening assay to identify targets of HIV-1 viral protein R dimerization.Attenuated Listeria monocytogenes vectors overcome suppressive plasma factors during HIV infection to stimulate myeloid dendritic cells to promote adaptive immunity and reactivation of latent virus.HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic interventionInfection history determines the differentiation state of human CD8+ T cellsPredictors of disease progression in HIV infection: a review.Dendritic cells infected with vpr-positive human immunodeficiency virus type 1 induce CD8+ T-cell apoptosis via upregulation of tumor necrosis factor alpha.A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cellsViral strategies for evading antiviral cellular immune responses of the host.Natural regulatory T cells and persistent viral infection.Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway.Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitopeInhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells.Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cellsIncreased B7-H1 expression on dendritic cells correlates with programmed death 1 expression on T cells in simian immunodeficiency virus-infected macaques and may contribute to T cell dysfunction and disease progression.Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis.Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.Memory T cells need CD28 costimulation to remember.Costimulation signals for memory CD8+ T cells during viral infections.Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?Dendritic cell dysregulation during HIV-1 infection.Blood and beyond: properties of circulating and tissue-resident human virus-specific αβ CD8(+) T cells.The influence of infectious factors on dendritic cell apoptosis.Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.HIV1-viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies.Nonspreading Rift Valley Fever Virus Infection of Human Dendritic Cells Results in Downregulation of CD83 and Full Maturation of Bystander Cells.Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasome.Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection.Dendritic Cell Response to HIV-1 Is Controlled by Differentiation Programs in the Cells and Strain-Specific Properties of the Virus.
P2860
Q21560946-5B3CA800-AB44-40B6-8627-A2B4D5FA995CQ27347896-A8E81189-E1B4-4076-99F0-50AD43AC76D3Q27486399-81A4D19B-735B-48E6-9BD5-A4461D29F1ADQ28068375-DAA3D7AD-56E1-4081-B34A-3CD3D0F0A536Q30373512-6F40ECB1-9437-412A-8748-BAF1A14282E9Q33466002-7B788163-C34D-46AC-BD68-94E2F8690C4EQ33510694-D509C8D3-A681-4613-9F3A-CAB3357825B7Q33637584-4B22A442-36B7-4F14-955A-924812C6BD23Q33759415-56F7CF57-FC82-45E9-A1CB-224209F5F478Q34263217-8FDA51F7-778B-46FA-AF41-91D1811C45D2Q34458060-204F04CE-8A39-4929-904F-23AEA324C71AQ34758051-30622886-F54A-4B7E-9615-FFE90039C627Q34871958-717B7C4F-CA00-4405-89D4-8694874A693EQ34957142-118DFB78-FDFA-4CDC-82CF-C6EBDF0DC92DQ35488692-FB48FD50-8C1A-4692-9E5E-81A9310EC5C1Q35834337-76CF011A-5EF8-48AE-912D-53AED7F68370Q35914471-7C266ACF-7EF7-4184-921F-80393AF5A528Q36229149-49EC3F92-C5D6-4664-9AA6-954C80E94164Q36276589-80F23AB5-6DFF-4556-9BBB-7F9E4A8FEAA2Q36423940-13EE9036-30FE-41B4-8BA6-1BED9EC0D77DQ36427991-BED5B651-34EC-4011-B0A4-7AA859385701Q36627951-66E4EF5F-4E8C-4DBA-94F6-BAE4338DCF81Q36706005-B04667E0-8D59-4A3B-A967-7CA07E95A829Q36747731-30A56E57-46AC-4744-A8C0-6A921C6F8534Q36937131-B61B9530-39C1-4F76-89A5-818A261B13A5Q37026262-3A08BCA3-FEC2-415A-9CDC-CEF3DA15EDADQ37063467-7AC0AF6E-71D0-4F9B-BB5E-976D32C77775Q37255184-D7797E0A-B5C7-4234-82A2-8F69303D46E2Q37408575-0A5547A8-ECF7-4267-9499-A551E4960649Q37685171-ECD371CC-A674-475B-9926-F87834C6DD64Q37728096-BA6245A7-4A07-4B93-AC94-E36FC392CA75Q38114911-C70009B1-955E-4B30-8129-26EE4DE59F1AQ38180622-30E701AC-C8C4-4F4C-9782-D9053A879CA9Q38623232-9690AD6E-FE6D-4CD0-9AC6-E20AECB629EAQ38727211-83A5469B-BC96-4CD2-AF86-8573D7A68F49Q38855423-7790984D-3AEF-425C-B8E9-AA4BEABB901AQ40130716-DECC4CFA-C009-4872-8E4C-0DC70E5FA993Q40146699-35E9B4E1-688A-49BC-9328-0FEAE3CB474EQ40151311-88D463A5-852D-4B0D-91A9-C046E87DF37EQ40271149-958B53AA-8547-4E7B-B91A-85AFC709C1BB
P2860
Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Human immunodeficiency virus t ...... tions for viral immune escape.
@ast
Human immunodeficiency virus t ...... tions for viral immune escape.
@en
type
label
Human immunodeficiency virus t ...... tions for viral immune escape.
@ast
Human immunodeficiency virus t ...... tions for viral immune escape.
@en
prefLabel
Human immunodeficiency virus t ...... tions for viral immune escape.
@ast
Human immunodeficiency virus t ...... tions for viral immune escape.
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus t ...... tions for viral immune escape.
@en
P2093
Biswanath Majumder
Charles R Rinaldo
Elizabeth A Schafer
June Kan-Mitchell
Keri Schaubert
Michelle L Janket
Velpandi Ayyavoo
Xiao-Li Huang
P2860
P304
P356
10.1128/JVI.79.13.7990-8003.2005
P577
2005-07-01T00:00:00Z